HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Shahzad G Raja Marco Pozzi Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Raja, S. G Articles by Pozzi, M. Search for Related Content PubMed PubMed Citation Articles by Raja, S. G Articles by Pozzi, M. Related Collections Great vessels Valve disease

Growth of Pulmonary Autograft After Ross Operation in Pediatric Patients

Department of Pediatric Cardiothoracic Surgery, Alder Hey Hospital, Liverpool, UK

For reprint information contact: Shahzad G Raja, MRCS Tel: 44 151 252 5635 Fax: 44 151 252 5643 Email: drrajashahzad{at}hotmail.com Department of Pediatric Cardiothoracic Surgery, Alder Hey Hospital (Royal Liverpool Children’s NHS Trust), Eaton Road, Liverpool L12 2AP, UK.

The Ross procedure is being used increasingly to treat aortic valve disease in pediatric patients; however, there is an ongoing dispute about the durability of the autograft. From November 1996 to September 2003, 32 pediatric patients (mean age, 11 ± 4.5 years) underwent the Ross procedure for various aortic valve diseases, using the root replacement technique. Clinical and echocardiographic follow-up was performed early (within 30 days), at 3 to 6 months, and yearly after surgery. There were no perioperative deaths. The patients were followed-up for up to 7 years with a median interval of 36 months. Actuarial survival at 7 years was 96% ± 3% and there was 100% freedom from re-operation for autograft valve dysfunction or any other cause. The autograft annulus and sinus increased significantly in size during follow-up and the increase in size paralleled the increase in body surface area, with no evidence of disproportional dilatation. The hemodynamics at the latest follow-up were also similar to those at the time of discharge after surgery. Pulmonary autograft replacement of the aortic valve appears to be the ideal solution in pediatric patients, because of relatively low operative risk, excellent late valve function, and real potential for growth.

This article has been cited by other articles:

				A. F. Corno, M. J. Kocica, and F. Torrent-Guasp The helical ventricular myocardial band of Torrent-Guasp: potential implications in congenital heart defects Eur. J. Cardiothorac. Surg., April 1, 2006; 29(Suppl_1): S61 - S68. [Abstract] [Full Text] [PDF]

				S. G. Raja Mechanism of autograft dilatation after Ross operation: some more insight please! Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 663 - 663. [Full Text] [PDF]